Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1114107 | 0.83 | ALDH1A1 (0.39) | HPGDALDH1A1 | |
| SCHEMBL15414871 | 0.80 | ALDH1A1 (0.38) | HPGDALDH1A1 | |
| SCHEMBL5597410 | 0.80 | ALDH1A1 (0.38) | HPGDALDH1A1 | |
| SCHEMBL4019405 | 0.80 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL2576954 | 0.78 | — | — | |
| SCHEMBL10578838 | 0.75 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL9796081 | 0.74 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL8681168 | 0.74 | ALDH1A1 (0.36) | ALDH1A1 | |
| Cyclohexane SCHEMBL15641920 | 0.74 | FFAR3 (0.33) | — | |
| SCHEMBL1582959 | 0.74 | KMT2A (0.48) | HPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007081530-A2 | ENDOLUMINAL MEDICAL DEVICE FOR LOCAL DELIVERY OF CATHEPSIN INHIBITORS | MED INSTITUTE, INC. (US) | 2007-07-19 | — | — | WO | claimed |
| US-20070293937-A1 | Endoluminal medical device for local delivery of cathepsin inhibitors, method of making and treating | MED INSTITUTE, INC. | 2007-12-20 | — | — | US | disclosed |
| WO-2007081530-A2 | ENDOLUMINAL MEDICAL DEVICE FOR LOCAL DELIVERY OF CATHEPSIN INHIBITORS | MED INSTITUTE, INC. (US) | 2007-07-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070293937-A1 | Endoluminal medical device for local delivery of cathepsin inhibitors, method of making and treating | CTSS, CTSD, CTSV | HPGD 1256/4885ALDH1A1 3476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.